Martine Rothblatt
2014
In 2014, Martine Rothblatt earned a total compensation of $33.2M as Chairman and Chief Executive Officer at United Therapeutics, a 13% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,633,033 |
|---|---|
| Non-Equity Incentive Plan | $1,073,981 |
| Option Awards | $29,460,128 |
| Salary | $1,024,524 |
| Other | $23,263 |
| Total | $33,214,929 |
Rothblatt received $29.5M in option awards, accounting for 89% of the total pay in 2014.
Rothblatt also received $1.6M of change in pension value and nonqualified deferred compensation earnings, $1.1M in non-equity incentive plan, $1M in salary and $23.3K in other compensation.
Rankings
In 2014, Martine Rothblatt's compensation ranked 40th out of 13,032 executives tracked by ExecPay. In other words, Rothblatt earned more than 99.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 40 out of 13,032 | 100th |
Division Manufacturing | 13 out of 4,967 | 100th |
Major group Chemicals And Allied Products | 7 out of 1,690 | 100th |
Industry group Drugs | 7 out of 1,369 | 100th |
Industry Pharmaceutical Preparations | 7 out of 1,042 | 99th |
Source: SEC filing on April 28, 2017.
Rothblatt's colleagues
We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2014.